Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/7/26 20:00 | 7/7/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | 4 | M.d | 15,444 | 59.40 | 0 | 260 | 64 | 667 | D | ||||||||||||||
7/7/26 20:00 | 7/7/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | 4 | S.d | -15,444 | 59.40 | 0 | -260 | 667 | D | |||||||||||||||
7/2/26 18:30 | 6/30/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | 3 | M.d | 9,218 | 60.99 | 0 | 151 | 139 | 260 | D | ||||||||||||||
7/2/26 18:30 | 6/30/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Jacobs Bruce N. | MA | O | CFO | 3 | S.d | -9,218 | 60.99 | 0 | -151 | 260 | D | |||||||||||||||
7/2/26 18:30 | 7/1/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Goodman Noah | MA | O | Chief Bu | 5 | S.d | -1,363 | 74.10 | 0 | -18 | 50 | D | |||||||||||||||
7/2/26 17:39 | 6/29/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | 8 | S.dm | -195,794 | 107.15 | 0 | -1,827 | 618 | I | ||||||||||||||||
6/26/26 18:48 | 6/26/26 | KYMR | Financ | InvAdv | Investment Advice | Bvf Partners L P/Il | CA | DH | See Rema | 1 | S.d | -173,665 | 106.50 | 0 | -1,631 | 319 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |